This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
New therapeutic approaches for multiple system atrophy with starting point alpha-synuclein Investments < €500k Germany 2016
Development of a blood-based early diagnosis of Alzheimer’s dementia Investments < €500k Germany 2016
Development of a new blood test for the diagnosis of Alzheimer’s disease Investments < €500k Germany 2016
Molecular analysis of neurodegeneration and muscular atrophy in amyotrophic lateral sclerosis Investments < €500k Germany 2016
Multimodal biomarkers for the longer-term prediction and staging of a probable Alzheimer’s disease in pre-dementia conditions Investments < €500k Germany 2016
Biopharmaceutical Neurology: Blood Assay for the Predictive and Early Diagnosis of Alzheimer’s Disease Investments < €500k Germany 2016
Description of causes of neurodegenerative disease mechanisms by producing amyloid beta aggregates from synthetic and patient material Investments < €500k Germany 2016
Uncertainty monitoring versus inhibition control: The role of subclude nuclues and effects of deep brain stimulation on oscillatory neuronal networks in Parkinson’s disease compared to compulsive disorder Investments < €500k Germany 2016
Immunotherapy of familial prion diseases Investments < €500k Germany 2016
Nanomodified antioxidants for the prevention and treatment of neurodegenerative diseases Investments < €500k Germany 2016
